VQ-101

N/A

Report date: 2024/04/10 14:54:08
NME

Base Information

Drug NameVQ-101
Drug Alias NameVQ-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucosylceramidase allosteric activators
TargetsGlucosylceramidase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVanqua Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesVanqua Bio Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A